# Exculpatory Language in Informed Consent - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/exculpatory-language-in-informed-consent/b715dc6a-852a-4eb2-b7e7-6f3773d248cc

> FDA guidance document: Exculpatory Language in Informed Consent. Issue date: August 19, 2011. Get complete insights and analysis.

---

## Details

- Title: Exculpatory Language in Informed Consent
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2011-08-19
- Comment Close Date: 2011-11-01
- Last Changed: 2021-07-21
- Docket Number: <a href="https://www.regulations.gov/docket/HHS-OPHS-2011-0014">HHS-OPHS-2011-0014</a>

## Related Documents

- [Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations](https://www.globalkeysolutions.net/guidances/guidance-document/bioavailability-and-bioequivalence-studies-submitted-in-ndas-or-inds-general-considerations/0cbdcef4-1b6b-45e5-8563-de1bb0a4e001)
- [Investigational New Drug Applications Prepared and Submitted by Sponsor-Investigators](https://www.globalkeysolutions.net/guidances/guidance-document/investigational-new-drug-applications-prepared-and-submitted-by-sponsor-investigators/9c10b828-60b1-4f2f-acda-7011cf2ad95d)
- [DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers](https://www.globalkeysolutions.net/guidances/guidance-document/dscsa-implementation-annual-reporting-by-prescription-drug-wholesale-distributors-and-third-party-logistics-providers/712ebdd8-de0d-4a6d-b6c3-0983093ca377)